Olive Capital

Olive Capital invests in trailblazing founders working in synthetic biology, software, and emergent platforms at the seed stage. Portfolio companies include Akasa, Science, TRLab, Ender, and Pardes. Historically, Olive Capital has invested in seed to early-stage companies in health care, biotechnology, and software industries, focusing on the United States, particularly in California and Colorado. The firm is based in San Francisco, CA.